Evidence map›Paper›PMID 32566676›Full record

ArticleBioMed research international2020

Development of a Novel Tool for the Retrieval and Analysis of Hormone Receptor Expression Characteristics in Metastatic Breast Cancer via Data Mining on Pathology Reports.

Kai-Po Chang, John Wang, Chi-Chang Chang, Yen-Wei Chu

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Kai-Po ChangPh.D. Program in Medical Biotechnology, National Chung Hsing University, Taichung 402, Taiwan.ORCID https://orcid.org/0000-0003-1730-9728
John WangDepartment of Pathology, China Medical University Hospital, Taichung 404, Taiwan.
Chi-Chang ChangSchool of Medical Informatics, Chung-Shan Medical University, Taichung 402, Taiwan.ORCID https://orcid.org/0000-0001-6513-9212
Yen-Wei ChuInstitute of Genomics and Bioinformatics, National Chung Hsing University, 145 Xingda Rd., South Dist., Taichung City 402, Taiwan.ORCID https://orcid.org/0000-0002-5525-4011
National Chung Hsing University · TWChina Medical University · TWChung Shan Medical University Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Information about the expression status of hormone receptors such as estrogen receptor (ER), progesterone receptor (PR), and Her-2 is crucial in the management and prognosis of breast cancer. Therefore, the retrieval and analysis of hormone receptor expression characteristics in metastatic breast cancer may be valuable in breast cancer study. Herein, we report a text mining tool based on word/phrase matching that retrieves hormone receptor expression data of regional or distant metastatic breast cancer from pathology reports. It was tested on pathology reports at the China Medical University Hospital from 2013 to 2018. The tool showed specificities of 91.6% and 63.3% for the detection of regional lymph node metastasis and distant metastasis, respectively. Sensitivity in immunohistochemical study result extraction in these cases was 98.6% for distant metastasis and 78.3% for regional lymph node metastasis. Statistical analysis on these retrieved data showed significant difference s in PR and Her-2 expressions between regional and metastatic breast cancer, which is compatible with previous studies. In conclusion, our study shows that metastatic breast cancer hormone receptor expression characteristics can be retrieved by text mining. The algorithm designed in this study may be useful in future studies about text mining in pathology reports.

Indexed as

Breast NeoplasmsAlgorithmsComputational BiologyData MiningErb-b2 Receptor Tyrosine KinasesFemaleHumansLymphatic MetastasisReceptors, EstrogenReceptors, ProgesteroneERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesReceptors, EstrogenReceptors, Progesterone

Identifiers

PMID32566676
PMCPMC7273481
OpenAlexW3028787604

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.